Consumer Product Stocks Feature Healthcare Stocks Precision Peptide Is Building the Infrastructure Behind the Peptide Boom Peptides have become one of the hottest corners of the longevity and… Wilson AugustineSeptember 11, 2026
Consumer Product Stocks Healthcare Stocks Precision Peptide’s Tirzepatide Patch Targets the Biggest Drug in the World Few molecules in pharmaceutical history have grown as fast as tirzepatide. Eli… Wilson AugustineAugust 26, 2026
Consumer Product Stocks Healthcare Stocks New Product Offering from Emerging Peptide Company Plus Executive Interview There’s an emerging peptide player that is making interesting strides in one… Stella EmoryAugust 4, 2026
Consumer Product Stocks Feature Top News FDA Panel Backs BPC-157, Right as Precision Peptide Goes Live Nationwide Timing matters in this business, and The Precision Peptide Company (CSE: BPC,… Wilson AugustineJuly 23, 2026
Consumer Product Stocks Healthcare Stocks Video Highlighting Upcoming Peptide Opportunity FDA’s Pharmacy Compounding Advisory Committee has a meeting on July 23-24, 2026,… Stella EmoryJuly 15, 2026
Consumer Product Stocks Healthcare Stocks The Pieces Are In Place: What The Precision Peptide Company’s Recent Moves Tell Investors A few weeks ago, The Precision Peptide Company (CSE: BPC / OTCQB:… Wilson AugustineJuly 9, 2026
Consumer Product Stocks Healthcare Stocks A New North American Player in the Peptide Market Body Protection Compound-157 (BPC-157) is a synthetic 15-amino-acid peptide originally derived from… Wilson AugustineJune 26, 2026